| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ... Journal of hepatology 73 (1), 202-209, 2020 | 3626 | 2020 |
| MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020 | 2918 | 2020 |
| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 2450 | 2023 |
| Non-alcoholic fatty liver disease EE Powell, VWS Wong, M Rinella The Lancet 397 (10290), 2212-2224, 2021 | 1891 | 2021 |
| Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ... Hepatology 65 (5), 1557-1565, 2017 | 1842 | 2017 |
| Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ... Hepatology 69 (6), 2672-2682, 2019 | 1804 | 2019 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1624 | 2018 |
| Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease VWS Wong, J Vergniol, GLH Wong, J Foucher, HLY Chan, B Le Bail, ... Hepatology 51 (2), 454-462, 2010 | 1546 | 2010 |
| New trends on obesity and NAFLD in Asia JG Fan, SU Kim, VWS Wong Journal of hepatology 67 (4), 862-873, 2017 | 1104 | 2017 |
| Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer J Yu, Q Feng, SH Wong, D Zhang, Q yi Liang, Y Qin, L Tang, H Zhao, ... Gut 66 (1), 70-78, 2017 | 1057 | 2017 |
| Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis T Karlas, D Petroff, M Sasso, JG Fan, YQ Mi, V de Lédinghen, M Kumar, ... Journal of hepatology 66 (5), 1022-1030, 2017 | 1044 | 2017 |
| Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis J Li, B Zou, YH Yeo, Y Feng, X Xie, DH Lee, H Fujii, Y Wu, LY Kam, F Ji, ... The lancet Gastroenterology & hepatology 4 (5), 389-398, 2019 | 952 | 2019 |
| Nonalcoholic fatty liver disease EM Brunt, VWS Wong, V Nobili, CP Day, S Sookoian, JJ Maher, ... Nature reviews Disease primers 1 (1), 1-22, 2015 | 893 | 2015 |
| Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis RS Taylor, RJ Taylor, S Bayliss, H Hagström, P Nasr, JM Schattenberg, ... Gastroenterology 158 (6), 1611-1625. e12, 2020 | 843 | 2020 |
| Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years VWS Wong, GLH Wong, PCL Choi, AWH Chan, MKP Li, HY Chan, ... Gut 59 (7), 969-974, 2010 | 826 | 2010 |
| Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients P Jiang, CWM Chan, KCA Chan, SH Cheng, J Wong, VWS Wong, ... Proceedings of the National Academy of Sciences 112 (11), E1317-E1325, 2015 | 740 | 2015 |
| Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients N Lee, KCA Chan, DS Hui, EKO Ng, A Wu, RWK Chiu, VWS Wong, ... Journal of clinical virology 31 (4), 304-309, 2004 | 737 | 2004 |
| A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek, GP Aithal, ... Hepatology 67 (5), 1754-1767, 2018 | 734 | 2018 |
| Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ... Clinical gastroenterology and hepatology 17 (4), 748-755. e3, 2019 | 728 | 2019 |
| Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study E Vilar-Gomez, L Calzadilla-Bertot, VWS Wong, M Castellanos, ... Gastroenterology 155 (2), 443-457. e17, 2018 | 726 | 2018 |